Clinical Trial Results:
A 28-Week, Phase 3, Randomized, Active Comparator and
Placebo-Controlled, Parallel Design Study to Evaluate the Efficacy
and Safety/Tolerability of Subcutaneous SCH 900222 / MK-3222,
Followed by an Optional Long-Term Safety Extension Study, in
Subjects With Moderate-to-Severe Chronic Plaque Psoriasis.
Summary
|
|
EudraCT number |
2013-001740-54 |
Trial protocol |
HU |
Global completion date |
31 Dec 2012
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
18 May 2019
|
First version publication date |
18 May 2019
|
Other versions |
|
Summary report(s) |
Cancelled/ Withdrawn Memo |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.